What is BioRestorative Therapies Inc (BRTX) stock price today?

BioRestorative Therapies Inc (BRTX) currently trades at $0.23 per share. The stock has a market capitalization of $5.86M and a P/E ratio of —x.

Is BRTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, BioRestorative Therapies Inc has a Smart Value Score of 13/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is BioRestorative Therapies Inc's revenue and earnings?

BioRestorative Therapies Inc has trailing twelve-month (TTM) revenue of $359700.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.58.

BRTX

BioRestorative Therapies Inc

NASDAQ: BRTX · HEALTHCARE · BIOTECHNOLOGY

$0.23

+11.60% today

Updated 2026-04-30

Market cap

$5.86M

P/E ratio

—

P/S ratio

16.28x

EPS (TTM)

$-1.58

Dividend yield

—

52W range

$0 – $2

Volume

10.4M

Market cap

$5.86M

P/E ratio

—

P/S ratio

16.28x

EPS (TTM)

$-1.58

Dividend yield

—

52W range

$0 – $2

Volume

10.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$8.00

+3453.98%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-2.45M

- Revenue declining -54.70% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$119800.00	$145800.00	$401000.00	$359700.00	$359700.00
Net income	$-13.22M	$-10.42M	$-8.98M	$-14.24M	$-3.21M
EPS	—	—	—	—	$-1.58
Free cash flow	$-6.35M	$-6.60M	$-8.34M	$-10.91M	$-2.45M
Profit margin	-11,036.97%	-7,145.20%	-2,239.25%	-3,959.40%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BRTX	$5.86M	13	5.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

BioRestorative Therapies Inc trades at $0.23. Our Smart Value Score of 13/100 indicates the stock is weak. TTM revenue stands at $359700.00.

Frequently asked questions

What is BioRestorative Therapies Inc's stock price?

BioRestorative Therapies Inc (BRTX) trades at $0.23.

Is BioRestorative Therapies Inc overvalued?

Smart Value Score 13/100 (Grade F, Strong Sell).

What is the price target of BioRestorative Therapies Inc (BRTX)?

The analyst target price is $8.00, representing +3454.0% upside from the current price of $0.23.

What is BioRestorative Therapies Inc's revenue?

TTM revenue is $359700.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio16.28x

ROE-320.50%

Beta0.27

50D MA$0.26

200D MA$1.09

Shares out0.03B

Float0.02B

Short ratio—

Avg volume10.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BRTX vs LLY →BRTX vs JNJ →BRTX vs ABBV →Stock screener →